West Pharmaceutical Services Long-Term Investments 2010-2024 | WST

West Pharmaceutical Services long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • West Pharmaceutical Services long-term investments for the quarter ending December 31, 2024 were $0.202B, a 3.76% decline year-over-year.
  • West Pharmaceutical Services long-term investments for 2024 were $0.202B, a 3.76% decline from 2023.
  • West Pharmaceutical Services long-term investments for 2023 were $0.21B, a 2.49% increase from 2022.
  • West Pharmaceutical Services long-term investments for 2022 were $0.205B, a 1.35% decline from 2021.
West Pharmaceutical Services Annual Long-Term Investments
(Millions of US $)
2024 $202
2023 $210
2022 $205
2021 $208
2020 $215
2019 $193
2018 $91
2017 $86
2016 $83
2015 $61
2014 $61
2013 $61
2012 $60
2011 $56
2010 $48
2009 $38
West Pharmaceutical Services Quarterly Long-Term Investments
(Millions of US $)
2024-12-31 $202
2024-09-30 $218
2024-06-30 $198
2024-03-31 $203
2023-12-31 $210
2023-09-30 $195
2023-06-30 $203
2023-03-31 $209
2022-12-31 $205
2022-09-30 $189
2022-06-30 $193
2022-03-31 $208
2021-12-31 $208
2021-09-30 $216
2021-06-30 $212
2021-03-31 $212
2020-12-31 $215
2020-09-30 $210
2020-06-30 $200
2020-03-31 $198
2019-12-31 $193
2019-09-30 $97
2019-06-30 $95
2019-03-31 $95
2018-12-31 $91
2018-09-30 $91
2018-06-30 $92
2018-03-31 $90
2017-12-31 $86
2017-09-30 $85
2017-06-30 $84
2017-03-31 $81
2016-12-31 $83
2016-09-30 $81
2016-06-30 $78
2016-03-31 $62
2015-12-31 $61
2015-09-30 $59
2015-06-30 $60
2015-03-31 $59
2014-12-31 $61
2014-09-30 $62
2014-06-30 $60
2014-03-31 $59
2013-12-31 $61
2013-09-30 $59
2013-06-30 $58
2013-03-31 $56
2012-12-31 $60
2012-09-30 $61
2012-06-30 $58
2012-03-31 $58
2011-12-31 $56
2011-09-30 $55
2011-06-30 $51
2011-03-31 $49
2010-12-31 $48
2010-09-30 $44
2010-06-30 $40
2010-03-31 $40
2009-12-31 $38
2009-09-30 $36
2009-06-30 $34
2009-03-31 $36
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $15.984B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47